| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51C DDX31 ATP5PO MYO1A ERCC6L TCP1 CCT2 KATNA1 MDN1 IQCA1 ACSBG1 NAV1 ATP1A2 ATP12A ATP2A2 ABCG8 | 1.49e-07 | 614 | 106 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX31 ATP5PO ERCC6L TCP1 CCT2 KATNA1 MDN1 IQCA1 NAV1 ATP1A2 ATP12A ATP2A2 ABCG8 | 6.16e-07 | 441 | 106 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.44e-06 | 5 | 106 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX31 ATP5PO GBP7 ERCC6L TCP1 CCT2 KATNA1 MDN1 SEPTIN3 IQCA1 NAV1 ATP1A2 ATP12A ATP2A2 ABCG8 | 1.45e-05 | 775 | 106 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 2.79e-05 | 2 | 106 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 2.79e-05 | 2 | 106 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 2.79e-05 | 2 | 106 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 2.79e-05 | 2 | 106 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX31 ATP5PO GBP7 ERCC6L TCP1 CCT2 KATNA1 MDN1 SEPTIN3 IQCA1 NAV1 ATP1A2 ATP12A ATP2A2 ABCG8 | 3.63e-05 | 839 | 106 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX31 ATP5PO GBP7 ERCC6L TCP1 CCT2 KATNA1 MDN1 SEPTIN3 IQCA1 NAV1 ATP1A2 ATP12A ATP2A2 ABCG8 | 3.68e-05 | 840 | 106 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX31 ATP5PO GBP7 ERCC6L TCP1 CCT2 KATNA1 MDN1 SEPTIN3 IQCA1 NAV1 ATP1A2 ATP12A ATP2A2 ABCG8 | 3.68e-05 | 840 | 106 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.66e-04 | 4 | 106 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.14e-04 | 172 | 106 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.13e-04 | 6 | 106 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP5PO COX8A RYR1 RYR3 SLC9C1 KCND3 SLC22A3 SCN4A ATP1A2 ATP12A ATP2A2 | 5.01e-04 | 627 | 106 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | L-leucine binding | 5.76e-04 | 7 | 106 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | amino acid binding | 6.16e-04 | 73 | 106 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 7.66e-04 | 8 | 106 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5PO COX8A RYR1 RYR3 SLC9C1 KCND3 SLC22A3 SCN4A ATP1A2 ATP12A ATP2A2 | 8.03e-04 | 664 | 106 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.32e-04 | 465 | 106 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 9.14e-04 | 36 | 106 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 9.14e-04 | 36 | 106 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | microtubule severing ATPase activity | 9.81e-04 | 9 | 106 | 2 | GO:0008568 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.22e-03 | 10 | 106 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.22e-03 | 10 | 106 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.44e-03 | 42 | 106 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 1.49e-03 | 11 | 106 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.87e-03 | 46 | 106 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.19e-03 | 171 | 106 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP5PO COX8A RYR1 RYR3 SLC9C1 KCND3 SLC22A3 SCN4A ATP1A2 ATP12A ATP2A2 | 2.31e-03 | 758 | 106 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | potassium ion binding | 2.44e-03 | 14 | 106 | 2 | GO:0030955 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.61e-03 | 178 | 106 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.72e-03 | 109 | 106 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | S100 protein binding | 2.80e-03 | 15 | 106 | 2 | GO:0044548 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 2.80e-03 | 15 | 106 | 2 | GO:0140776 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP5PO COX8A RYR1 RYR3 SLC9C1 KCND3 SLC22A3 SCN4A ATP1A2 ATP12A ATP2A2 | 3.26e-03 | 793 | 106 | 11 | GO:0015075 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.42e-05 | 185 | 106 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 4.43e-05 | 14 | 106 | 3 | GO:0099569 | |
| GeneOntologyCellularComponent | sarcolemma | 5.24e-05 | 190 | 106 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | postsynapse | CABP1 COL13A1 ABR LZTS3 RPS3A WNT5A NTRK3 PCLO ITGB3 ELFN2 KCND3 UBE3A DLG1 RIMS1 CTNNB1 ATP1A2 | 5.30e-05 | 1018 | 106 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 7.08e-05 | 137 | 106 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RAD51C CABP1 GBP7 PCLO ADGRV1 RYR1 RYR3 MALT1 KCND3 PKHD1 DLG1 PLD1 CTNNB1 ATP2A2 SNX5 | 7.30e-05 | 934 | 106 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | platelet alpha granule membrane | 8.18e-05 | 17 | 106 | 3 | GO:0031092 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.11e-04 | 49 | 106 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.17e-04 | 94 | 106 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.72e-04 | 230 | 106 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 1.75e-04 | 55 | 106 | 4 | GO:0098533 | |
| GeneOntologyCellularComponent | apical plasma membrane | MYO1A ITGB3 STXBP2 SLC22A3 PKHD1 DLG1 PLD1 CTNNB1 ATP12A ABCG8 | 1.86e-04 | 487 | 106 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.87e-04 | 56 | 106 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 1.87e-04 | 56 | 106 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.08e-04 | 23 | 106 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | apical part of cell | MYO1A NEDD1 ITGB3 STXBP2 SLC22A3 PKHD1 DLG1 PLD1 CTNNB1 ATP12A ABCG8 | 2.09e-04 | 592 | 106 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | organelle envelope | H2BW1 FKBP10 RHBDD1 ATP5PO DPY19L2 NTRK3 COX8A CPS1 PHF8 TXNDC12 TYRO3 SLC44A1 GK SLC22A3 GLUD1 GLUD2 RAB11FIP5 CTNNB1 | 3.04e-04 | 1435 | 106 | 18 | GO:0031967 |
| GeneOntologyCellularComponent | transmembrane transporter complex | ATP5PO COX8A RYR1 RYR3 KCND3 SCN4A ATP1A2 ATP12A ATP2A2 ABCG8 | 3.28e-04 | 523 | 106 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | manchette | 3.79e-04 | 28 | 106 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | intercalated disc | 3.96e-04 | 68 | 106 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | transporter complex | ATP5PO COX8A RYR1 RYR3 KCND3 SCN4A ATP1A2 ATP12A ATP2A2 ABCG8 | 4.86e-04 | 550 | 106 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | cell cortex | 6.07e-04 | 371 | 106 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | COL13A1 ITGAL ITGB3 RYR1 KCND3 AHNAK SCN4A DLG1 CTNNB1 ATP1A2 ATP12A ABCG8 | 6.28e-04 | 785 | 106 | 12 | GO:0098797 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 6.99e-04 | 8 | 106 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | T-tubule | 7.01e-04 | 79 | 106 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | mitochondrial envelope | FKBP10 RHBDD1 ATP5PO NTRK3 COX8A CPS1 TXNDC12 SLC44A1 GK SLC22A3 GLUD1 GLUD2 RAB11FIP5 | 7.11e-04 | 912 | 106 | 13 | GO:0005740 |
| GeneOntologyCellularComponent | junctional membrane complex | 8.96e-04 | 9 | 106 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.05e-03 | 503 | 106 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.14e-03 | 230 | 106 | 6 | GO:0019898 | |
| GeneOntologyCellularComponent | zona pellucida receptor complex | 1.36e-03 | 11 | 106 | 2 | GO:0002199 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 1.36e-03 | 11 | 106 | 2 | GO:0005832 | |
| GeneOntologyCellularComponent | membrane protein complex | COL13A1 ATP5PO COX8A ITGAL ITGB3 RYR1 RYR3 KCND3 AHNAK SCN4A DLG1 CTNNB1 ATP1A2 ATP12A ATP2A2 ABCG8 SNX5 | 1.39e-03 | 1498 | 106 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | mitochondrial membrane | RHBDD1 ATP5PO NTRK3 COX8A CPS1 TXNDC12 SLC44A1 GK SLC22A3 GLUD1 GLUD2 RAB11FIP5 | 1.46e-03 | 866 | 106 | 12 | GO:0031966 |
| GeneOntologyCellularComponent | cell cortex region | 1.54e-03 | 45 | 106 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.54e-03 | 45 | 106 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.97e-03 | 49 | 106 | 3 | GO:0090533 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.11e-03 | 451 | 106 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | cell body | CABP1 FLNB MYO1A TCP1 PCLO CCT2 KATNA1 PTPRN KCND3 SLC22A3 DLG1 ATP1A2 | 2.62e-03 | 929 | 106 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | synaptic membrane | 2.87e-03 | 583 | 106 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CABP1 ABR LZTS3 WNT5A NTRK3 PCLO ITGB3 UBE3A DLG1 RIMS1 CTNNB1 | 2.89e-03 | 817 | 106 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | asymmetric synapse | 2.97e-03 | 477 | 106 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | organelle outer membrane | 3.00e-03 | 279 | 106 | 6 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 3.11e-03 | 281 | 106 | 6 | GO:0019867 | |
| GeneOntologyCellularComponent | microvillus | 3.57e-03 | 123 | 106 | 4 | GO:0005902 | |
| GeneOntologyCellularComponent | secretory vesicle | CABP1 TCP1 CCT2 ITGAL ITGB3 STXBP2 PTPRN UBE3A RAB11FIP5 DLG1 PRKG1 PLD1 TMX3 CYB5R1 | 4.13e-03 | 1246 | 106 | 14 | GO:0099503 |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.59e-03 | 405 | 106 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | myelin sheath | 5.00e-03 | 217 | 106 | 5 | GO:0043209 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 5.16e-03 | 523 | 106 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | secretory granule | CABP1 TCP1 CCT2 ITGAL ITGB3 STXBP2 PTPRN RAB11FIP5 PRKG1 PLD1 TMX3 CYB5R1 | 5.28e-03 | 1014 | 106 | 12 | GO:0030141 |
| MousePheno | abnormal muscle relaxation | 2.20e-06 | 61 | 88 | 6 | MP:0004036 | |
| MousePheno | ectopic manchette | 5.29e-06 | 19 | 88 | 4 | MP:0009377 | |
| MousePheno | detached acrosome | 7.89e-06 | 44 | 88 | 5 | MP:0009231 | |
| MousePheno | abnormal manchette morphology | 8.83e-06 | 45 | 88 | 5 | MP:0009376 | |
| MousePheno | abnormal cardiac muscle relaxation | 4.05e-05 | 31 | 88 | 4 | MP:0004084 | |
| MousePheno | abnormal muscle contractility | DUSP8 ITGB3 TXNDC12 RYR1 RYR3 SCN4A DLG1 PRKG1 ATP1A2 ATP2A2 ABCG8 | 6.05e-05 | 418 | 88 | 11 | MP:0005620 |
| MousePheno | impaired muscle contractility | 1.03e-04 | 297 | 88 | 9 | MP:0000738 | |
| Domain | ELFV_dehydrog_N | 3.19e-05 | 2 | 106 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 3.19e-05 | 2 | 106 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 3.19e-05 | 2 | 106 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 3.19e-05 | 2 | 106 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 3.19e-05 | 2 | 106 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 3.19e-05 | 2 | 106 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 3.19e-05 | 2 | 106 | 2 | PS00074 | |
| Domain | ELFV_dehydrog | 3.19e-05 | 2 | 106 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 3.19e-05 | 2 | 106 | 2 | IPR033524 | |
| Domain | ATPase_P-typ_TM_dom | 9.43e-05 | 16 | 106 | 3 | IPR023298 | |
| Domain | - | 9.43e-05 | 16 | 106 | 3 | 1.20.1110.10 | |
| Domain | Ryanodine_rcpt | 9.54e-05 | 3 | 106 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 9.54e-05 | 3 | 106 | 2 | IPR009460 | |
| Domain | RyR | 9.54e-05 | 3 | 106 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 9.54e-05 | 3 | 106 | 2 | PF06459 | |
| Domain | Ryan_recept | 9.54e-05 | 3 | 106 | 2 | IPR013333 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.14e-04 | 17 | 106 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.14e-04 | 17 | 106 | 3 | PF00689 | |
| Domain | SH3_2 | 1.29e-04 | 86 | 106 | 5 | PF07653 | |
| Domain | SH3_2 | 1.29e-04 | 86 | 106 | 5 | IPR011511 | |
| Domain | Cation_ATPase_N | 1.36e-04 | 18 | 106 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 1.36e-04 | 18 | 106 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.61e-04 | 19 | 106 | 3 | IPR004014 | |
| Domain | RIH_assoc-dom | 4.72e-04 | 6 | 106 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 4.72e-04 | 6 | 106 | 2 | PF08709 | |
| Domain | RIH_assoc | 4.72e-04 | 6 | 106 | 2 | PF08454 | |
| Domain | RIH_dom | 4.72e-04 | 6 | 106 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.72e-04 | 6 | 106 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.72e-04 | 6 | 106 | 2 | IPR015925 | |
| Domain | - | 4.72e-04 | 6 | 106 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.72e-04 | 6 | 106 | 2 | PF01365 | |
| Domain | P-type_ATPase_IIC | 4.72e-04 | 6 | 106 | 2 | IPR005775 | |
| Domain | Ion_trans_dom | 4.81e-04 | 114 | 106 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.81e-04 | 114 | 106 | 5 | PF00520 | |
| Domain | - | 7.82e-04 | 32 | 106 | 3 | 3.40.1110.10 | |
| Domain | - | 7.82e-04 | 32 | 106 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.02e-03 | 35 | 106 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.11e-03 | 36 | 106 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.11e-03 | 36 | 106 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.11e-03 | 36 | 106 | 3 | PS00154 | |
| Domain | Chaprnin_Cpn60 | 1.12e-03 | 9 | 106 | 2 | IPR001844 | |
| Domain | Chaperonin_TCP-1_CS | 1.12e-03 | 9 | 106 | 2 | IPR002194 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.20e-03 | 37 | 106 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.20e-03 | 37 | 106 | 3 | PF00122 | |
| Domain | VWFA | 1.22e-03 | 82 | 106 | 4 | PS50234 | |
| Domain | VWA | 1.33e-03 | 84 | 106 | 4 | SM00327 | |
| Domain | MIR | 1.39e-03 | 10 | 106 | 2 | PF02815 | |
| Domain | MIR_motif | 1.39e-03 | 10 | 106 | 2 | IPR016093 | |
| Domain | TCP1_1 | 1.39e-03 | 10 | 106 | 2 | PS00750 | |
| Domain | TCP1_2 | 1.39e-03 | 10 | 106 | 2 | PS00751 | |
| Domain | TCP1_3 | 1.39e-03 | 10 | 106 | 2 | PS00995 | |
| Domain | MIR | 1.39e-03 | 10 | 106 | 2 | PS50919 | |
| Domain | MIR | 1.39e-03 | 10 | 106 | 2 | SM00472 | |
| Domain | Chaperone_TCP-1 | 1.39e-03 | 10 | 106 | 2 | IPR017998 | |
| Domain | Znf_FYVE_PHD | 1.51e-03 | 147 | 106 | 5 | IPR011011 | |
| Domain | - | 1.70e-03 | 11 | 106 | 2 | 3.30.260.10 | |
| Domain | TCP-1-like_intermed | 1.70e-03 | 11 | 106 | 2 | IPR027410 | |
| Domain | VWF_A | 2.44e-03 | 99 | 106 | 4 | IPR002035 | |
| Domain | GROEL-like_equatorial | 2.78e-03 | 14 | 106 | 2 | IPR027413 | |
| Domain | - | 2.78e-03 | 14 | 106 | 2 | 1.10.560.10 | |
| Domain | P-loop_NTPase | RAD51C DDX31 MYO1A GBP7 ERCC6L KATNA1 MDN1 SEPTIN3 IQCA1 NAV1 DLG1 ABCG8 | 3.11e-03 | 848 | 106 | 12 | IPR027417 |
| Domain | GroEL-like_apical_dom | 3.19e-03 | 15 | 106 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 3.19e-03 | 15 | 106 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 3.19e-03 | 15 | 106 | 2 | PF00118 | |
| Domain | - | 3.19e-03 | 15 | 106 | 2 | 3.50.7.10 | |
| Domain | - | RAD51C DDX31 GBP7 ERCC6L KATNA1 MDN1 SEPTIN3 IQCA1 NAV1 DLG1 ABCG8 | 3.40e-03 | 746 | 106 | 11 | 3.40.50.300 |
| Domain | Thioredoxin_CS | 4.10e-03 | 17 | 106 | 2 | IPR017937 | |
| Domain | FN3 | 5.55e-03 | 199 | 106 | 5 | PS50853 | |
| Pubmed | FLNB MACC1 IRS4 ATP5PO MYO1A CHAF1A PCLO HMGB3 CCT2 MDN1 STXBP2 FUBP1 AHNAK SCN4A GLUD1 GLUD2 PKHD1 DLG1 RIMS1 ATP1A2 ATP12A ATP2A2 | 3.62e-10 | 1442 | 106 | 22 | 35575683 | |
| Pubmed | 3.90e-10 | 136 | 106 | 9 | 22304920 | ||
| Pubmed | FLNB LZTS3 PCLO USP24 BIRC6 ELFN2 TXNDC12 SEPTIN3 ACSBG1 KCND3 UBE3A GLUD1 GLUD2 NAV1 DLG1 RIMS1 CTNNB1 ATP1A2 ATP2A2 | 1.60e-09 | 1139 | 106 | 19 | 36417873 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNB USP24 CCT2 CPS1 BIRC6 DDB1 ITGB3 MDN1 STXBP2 GLUD1 GLUD2 | 9.10e-09 | 344 | 106 | 11 | 30333137 |
| Pubmed | FLNB ATP5PO LZTS3 TCP1 RPS3A PCLO CCT2 DDB1 ELFN2 SLC44A1 KCND3 GLUD1 GLUD2 NAV1 DLG1 RIMS1 CTNNB1 ATP1A2 FH ATP2A2 | 1.13e-08 | 1431 | 106 | 20 | 37142655 | |
| Pubmed | FLNB IRS4 DDX31 RPS3A USP24 CCT2 BIRC6 DDB1 TGM3 MDN1 AHNAK UTP20 FH ATP2A2 | 1.27e-08 | 653 | 106 | 14 | 22586326 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNB DDX31 TCP1 RPS3A CHAF1A CCT2 MCM10 DDB1 TXNDC12 PPP1R10 MDN1 FUBP1 AHNAK UTP20 CTNNB1 ATP2A2 | 5.46e-08 | 989 | 106 | 16 | 36424410 |
| Pubmed | FLNB IRS4 ATP5PO TCP1 RPS3A HMGB3 CCT2 DLG1 CTNNB1 ATP2A2 SNX5 | 5.59e-08 | 411 | 106 | 11 | 36652389 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP5PO TCP1 RPS3A KDM5C PCLO CCT2 SEPTIN3 GLUD1 GLUD2 RAB11FIP5 CTNNB1 ATP12A ATP2A2 | 5.78e-08 | 621 | 106 | 13 | 22794259 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FKBP10 FLNB IRS4 TCP1 RPS3A HMGB3 CCT2 DDB1 TXNDC12 MDN1 STXBP2 FUBP1 AHNAK GLUD1 EIF3J ATP2A2 SNX5 | 7.25e-08 | 1149 | 106 | 17 | 35446349 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB IRS4 ATP5PO TCP1 RPS3A CCT2 DDB1 PPP1R10 MDN1 STXBP2 FUBP1 AHNAK GLUD1 UTP20 CTNNB1 ATP2A2 | 8.77e-08 | 1024 | 106 | 16 | 24711643 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 9.72e-08 | 256 | 106 | 9 | 35777956 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.10e-07 | 4 | 106 | 3 | 19091768 | |
| Pubmed | IRS4 ZBTB33 KMT2B ERCC6L TCP1 USP24 CCT2 PHF8 PPP1R10 AHNAK DLG1 DOT1L | 1.22e-07 | 549 | 106 | 12 | 38280479 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 2.17e-07 | 203 | 106 | 8 | 16916647 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RAD51C IRS4 ZBTB33 ATP5PO TCP1 RPS3A CCT2 BIRC6 DDB1 ELAC2 MDN1 UBE3A GLUD1 GLUD2 CTNNB1 TMX3 ATP2A2 | 2.58e-07 | 1257 | 106 | 17 | 37317656 |
| Pubmed | FLNB ZBTB33 ABR ERCC6L TCP1 RPS3A USP24 CCT2 DDB1 AHNAK RAB11FIP5 DLG1 ATP2A2 | 2.59e-07 | 708 | 106 | 13 | 39231216 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.61e-07 | 208 | 106 | 8 | 33230847 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.74e-07 | 5 | 106 | 3 | 17855024 | |
| Pubmed | TCP1 KDM5C CHAF1A HMGB3 CCT2 PHF8 DDB1 ELAC2 PPP1R10 MDN1 UBE3A FUBP1 AHNAK CTNNB1 EIF3J | 4.61e-07 | 1014 | 106 | 15 | 32416067 | |
| Pubmed | ATP5PO TCP1 CCT2 SEPTIN3 GLUD1 GLUD2 DLG1 CTNNB1 ATP1A2 ATP2A2 | 4.63e-07 | 403 | 106 | 10 | 30562941 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNB DPYS COL15A1 TCP1 CCT2 ADGRV1 HNMT DDB1 RYR1 SLC44A1 GK STXBP2 AHNAK PKHD1 BBOX1 | 4.73e-07 | 1016 | 106 | 15 | 19056867 |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 6.71e-07 | 54 | 106 | 5 | 31792442 | |
| Pubmed | IRS4 DDX31 TCP1 DUSP8 CCT2 PHF8 BIRC6 TXNDC12 PPP1R10 PTPRN AHNAK RAB11FIP5 DLG1 ATP2A2 PHLPP2 | 7.06e-07 | 1049 | 106 | 15 | 27880917 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.61e-07 | 332 | 106 | 9 | 32786267 | |
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.52e-06 | 8 | 106 | 3 | 19033399 | |
| Pubmed | FKBP10 FLNB ATP5PO TCP1 USP24 CCT2 NEDD1 BIRC6 ELAC2 TXNDC12 FUBP1 AHNAK TTC13 CTNNB1 TMX3 ATP2A2 | 2.00e-06 | 1297 | 106 | 16 | 33545068 | |
| Pubmed | 2.08e-06 | 191 | 106 | 7 | 33762435 | ||
| Pubmed | FKBP10 ATP5PO COX8A PHF8 TXNDC12 STXBP2 GLUD1 RAB11FIP5 CTNNB1 FH TMX3 ATP2A2 CYB5R1 | 2.23e-06 | 859 | 106 | 13 | 31536960 | |
| Pubmed | IRS4 ATP5PO TCP1 RPS3A CCT2 CPS1 PHF8 DDB1 ELAC2 MDN1 GLUD1 ATP2A2 | 2.27e-06 | 725 | 106 | 12 | 27025967 | |
| Pubmed | 2.55e-06 | 197 | 106 | 7 | 31620119 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 FLNB KMT2B TCP1 PCLO PHF8 BIRC6 RYR1 MDN1 AHNAK PKHD1 UTP20 | 2.64e-06 | 736 | 106 | 12 | 29676528 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IRS4 COL15A1 ATP5PO TCP1 PCLO CCT2 BIRC6 DDB1 ELAC2 GK MDN1 FUBP1 GLUD1 NAV1 TTC13 ATP2A2 CYB5R1 | 2.80e-06 | 1496 | 106 | 17 | 32877691 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB TCP1 RPS3A CCT2 MCM10 PHF8 BIRC6 DDB1 ELAC2 TGM3 MDN1 UBE3A FUBP1 AHNAK UTP20 ATP2A2 | 3.44e-06 | 1353 | 106 | 16 | 29467282 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FKBP10 RHBDD1 COL15A1 ATP5PO WNT5A DDB1 ELAC2 TXNDC12 SLC22A3 UTP20 TTC13 CTNNB1 TMX3 ATP2A2 SNX5 | 3.72e-06 | 1201 | 106 | 15 | 35696571 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FKBP10 FLNB ZBTB33 ATP5PO TCP1 HMGB3 CCT2 DDB1 TGM3 AHNAK GLUD1 DLG1 CTNNB1 EIF3J FH ATP2A2 | 3.92e-06 | 1367 | 106 | 16 | 32687490 |
| Pubmed | FLNB IRS4 ERCC6L TCP1 RPS3A USP24 CCT2 DDB1 MDN1 CTNNB1 ATP2A2 | 4.18e-06 | 638 | 106 | 11 | 33239621 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B ERCC6L KDM5C CHAF1A USP24 PHF8 MDN1 FUBP1 DLG1 UTP20 RIMS1 ATP2A2 | 4.42e-06 | 774 | 106 | 12 | 15302935 |
| Pubmed | ZBTB33 ATP5PO ABR DDB1 TXNDC12 ARHGEF10L PPP1R10 TGM3 FUBP1 AHNAK GLUD1 DLG1 CTNNB1 | 4.49e-06 | 916 | 106 | 13 | 32203420 | |
| Pubmed | 5.10e-06 | 81 | 106 | 5 | 26990986 | ||
| Pubmed | 5.64e-06 | 418 | 106 | 9 | 35338135 | ||
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 19095005 | ||
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 7896292 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB ATP5PO TCP1 RPS3A USP24 CCT2 CPS1 BIRC6 DDB1 ELAC2 TXNDC12 AHNAK GLUD1 NAV1 EIF3J ATP2A2 | 6.05e-06 | 1415 | 106 | 16 | 28515276 |
| Pubmed | 6.09e-06 | 538 | 106 | 10 | 28524877 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB IRS4 ATP5PO TCP1 RPS3A CHAF1A PCLO CCT2 DDB1 TGM3 MDN1 FUBP1 GLUD1 UTP20 FH ATP2A2 | 6.61e-06 | 1425 | 106 | 16 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB IRS4 COL13A1 TCP1 PCLO CCT2 DDB1 RYR1 MDN1 AHNAK FH ATP2A2 | 6.73e-06 | 807 | 106 | 12 | 30575818 |
| Pubmed | 7.08e-06 | 430 | 106 | 9 | 32581705 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FKBP10 FLNB TCP1 RPS3A USP24 HMGB3 CCT2 BIRC6 DDB1 ELAC2 UBE3A FUBP1 AHNAK EIF3J FH SNX5 | 8.57e-06 | 1455 | 106 | 16 | 22863883 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZBTB33 ERCC6L MCM10 CPS1 NEDD1 PPP1R10 FUBP1 AHNAK RAB11FIP5 | 9.14e-06 | 444 | 106 | 9 | 34795231 |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34173171 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28621566 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32078638 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23595828 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21621574 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9489997 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28911206 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22875990 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 9.20e-06 | 2 | 106 | 2 | 12640042 | |
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 9.20e-06 | 2 | 106 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 9.20e-06 | 2 | 106 | 2 | 15044002 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 9.20e-06 | 2 | 106 | 2 | 22138648 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 14592949 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34220417 | ||
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 9.20e-06 | 2 | 106 | 2 | 26241911 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21446915 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38060673 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9799464 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24593767 | ||
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 9.20e-06 | 2 | 106 | 2 | 37154294 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22924626 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24674304 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11032875 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29943084 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 9.20e-06 | 2 | 106 | 2 | 17118445 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31898404 | ||
| Pubmed | Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. | 9.20e-06 | 2 | 106 | 2 | 15378063 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27422263 | ||
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 9.20e-06 | 2 | 106 | 2 | 11500519 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25704758 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15750346 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1711373 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20603606 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 35151329 | ||
| Pubmed | Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. | 9.20e-06 | 2 | 106 | 2 | 20529287 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25124006 | ||
| Pubmed | Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. | 9.20e-06 | 2 | 106 | 2 | 17992121 | |
| Pubmed | Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase. | 9.20e-06 | 2 | 106 | 2 | 23673664 | |
| Pubmed | Lack of evidence for direct ligand-gated ion channel activity of GluD receptors. | 9.20e-06 | 2 | 106 | 2 | 39052831 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12565913 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24442550 | ||
| Pubmed | Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma. | 9.20e-06 | 2 | 106 | 2 | 25031739 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9192302 | ||
| Pubmed | The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity. | 9.20e-06 | 2 | 106 | 2 | 27137930 | |
| Pubmed | GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution. | 9.20e-06 | 2 | 106 | 2 | 26440896 | |
| Pubmed | Wnt5a/β-catenin signaling drives calcium-induced differentiation of human primary keratinocytes. | 9.20e-06 | 2 | 106 | 2 | 24658506 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12742085 | ||
| Pubmed | TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin. | 9.20e-06 | 2 | 106 | 2 | 31570854 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7556644 | ||
| Interaction | KCNA3 interactions | FLNB IRS4 ZBTB33 ABR ERCC6L TCP1 RPS3A USP24 CCT2 DDB1 RYR1 AHNAK PKHD1 RAB11FIP5 DLG1 RIMS1 ATP2A2 | 2.51e-06 | 871 | 105 | 17 | int:KCNA3 |
| Interaction | BAP1 interactions | FKBP10 FLNB IRS4 TCP1 RPS3A KDM5C HMGB3 CCT2 CPS1 DDB1 TXNDC12 MDN1 STXBP2 FUBP1 AHNAK GLUD1 CTNNB1 EIF3J FH ATP2A2 SNX5 | 3.49e-06 | 1314 | 105 | 21 | int:BAP1 |
| Interaction | ATF2 interactions | 5.83e-06 | 247 | 105 | 9 | int:ATF2 | |
| Interaction | PTEN interactions | FKBP10 FLNB IRS4 TCP1 CCT2 NEDD1 BIRC6 DDB1 RYR3 PPP1R10 MDN1 SEPTIN3 FUBP1 GLUD1 DLG1 CTNNB1 ATP2A2 | 5.94e-06 | 929 | 105 | 17 | int:PTEN |
| Interaction | HTT interactions | ATP5PO ERCC6L TCP1 RPS3A KDM5C PCLO USP24 CCT2 DDB1 ITGB3 PPP1R10 SEPTIN3 GLUD1 RAB11FIP5 CTNNB1 ATP12A ATP2A2 | 7.86e-06 | 949 | 105 | 17 | int:HTT |
| Interaction | EIF6 interactions | 2.11e-05 | 365 | 105 | 10 | int:EIF6 | |
| Interaction | B3GNT2 interactions | FKBP10 TCP1 RPS3A UGT1A7 CCT2 CPS1 ITGB3 TGM3 AHNAK TTC13 EIF3J ATP2A2 | 2.55e-05 | 542 | 105 | 12 | int:B3GNT2 |
| Interaction | SIRT7 interactions | FLNB IRS4 DDX31 RPS3A USP24 CCT2 BIRC6 DDB1 TGM3 MDN1 AHNAK UTP20 FH ATP2A2 | 3.16e-05 | 744 | 105 | 14 | int:SIRT7 |
| Interaction | ATP1A1 interactions | FLNB TCP1 COX8A CCT2 CPS1 ITGB3 TYRO3 UBE3A CTNNB1 ATP1A2 ATP12A ATP2A2 | 4.53e-05 | 575 | 105 | 12 | int:ATP1A1 |
| Interaction | PPT1 interactions | 5.86e-05 | 256 | 105 | 8 | int:PPT1 | |
| Interaction | OBSL1 interactions | FLNB ATP5PO TCP1 RPS3A PCLO CCT2 PHF8 DDB1 PPP1R10 SLC9C1 MDN1 FUBP1 AHNAK UTP20 CTNNB1 | 6.65e-05 | 902 | 105 | 15 | int:OBSL1 |
| Interaction | ITGB2 interactions | 6.67e-05 | 132 | 105 | 6 | int:ITGB2 | |
| Interaction | PHF21A interactions | 7.73e-05 | 343 | 105 | 9 | int:PHF21A | |
| Interaction | PPP5C interactions | 8.95e-05 | 272 | 105 | 8 | int:PPP5C | |
| Interaction | FGD5 interactions | 1.06e-04 | 207 | 105 | 7 | int:FGD5 | |
| Interaction | PDK1 interactions | 1.16e-04 | 362 | 105 | 9 | int:PDK1 | |
| Interaction | MAP1B interactions | ATP5PO TCP1 CCT2 CPS1 DDB1 ITGB3 PYHIN1 GLUD1 GLUD2 ATP1A2 ATP2A2 | 1.17e-04 | 539 | 105 | 11 | int:MAP1B |
| Interaction | NR4A1 interactions | 1.23e-04 | 212 | 105 | 7 | int:NR4A1 | |
| Interaction | ARHGEF15 interactions | 1.23e-04 | 49 | 105 | 4 | int:ARHGEF15 | |
| Interaction | DUX4 interactions | 1.30e-04 | 214 | 105 | 7 | int:DUX4 | |
| Interaction | PARP16 interactions | 1.33e-04 | 50 | 105 | 4 | int:PARP16 | |
| Interaction | MCM2 interactions | FLNB ATP5PO TCP1 RPS3A CHAF1A CCT2 MCM10 ITGB3 PYHIN1 TGM3 UBE3A FUBP1 AHNAK GLUD1 GLUD2 CTNNB1 | 1.46e-04 | 1081 | 105 | 16 | int:MCM2 |
| Interaction | SCN4A interactions | 1.61e-04 | 98 | 105 | 5 | int:SCN4A | |
| Interaction | AURKB interactions | IRS4 ATP5PO ABR MYO1A TCP1 RPS3A CCT2 ADGRV1 CPS1 DDB1 AHNAK CTNNB1 ATP2A2 | 1.63e-04 | 761 | 105 | 13 | int:AURKB |
| Interaction | DAZ2 interactions | 1.71e-04 | 21 | 105 | 3 | int:DAZ2 | |
| Interaction | PNPLA1 interactions | 1.71e-04 | 21 | 105 | 3 | int:PNPLA1 | |
| Interaction | TUBG1 interactions | 1.74e-04 | 382 | 105 | 9 | int:TUBG1 | |
| Interaction | ANKRD55 interactions | 1.92e-04 | 228 | 105 | 7 | int:ANKRD55 | |
| Interaction | HDAC1 interactions | FLNB IRS4 ZBTB33 KMT2B TCP1 KDM5C CHAF1A USP24 CCT2 BIRC6 DDB1 AHNAK NAV1 PRKG1 CTNNB1 DOT1L | 1.93e-04 | 1108 | 105 | 16 | int:HDAC1 |
| Interaction | ACTR3 interactions | 1.96e-04 | 305 | 105 | 8 | int:ACTR3 | |
| Interaction | CFTR interactions | CFAP47 FLNB IRS4 ATP5PO MYO1A ERCC6L RPS3A CCT2 HNMT DDB1 RYR3 TGM3 MDN1 UBE3A AHNAK DLG1 PRKG1 CTNNB1 ATP2A2 | 2.11e-04 | 1480 | 105 | 19 | int:CFTR |
| Interaction | RNF41 interactions | 2.19e-04 | 164 | 105 | 6 | int:RNF41 | |
| Interaction | SET interactions | 2.24e-04 | 311 | 105 | 8 | int:SET | |
| Interaction | DCAF4L1 interactions | 2.26e-04 | 23 | 105 | 3 | int:DCAF4L1 | |
| Interaction | DUSP16 interactions | 2.44e-04 | 237 | 105 | 7 | int:DUSP16 | |
| Interaction | XPC interactions | 2.50e-04 | 168 | 105 | 6 | int:XPC | |
| Interaction | CDK1 interactions | ERCC6L TCP1 NTRK3 PHF8 NEDD1 ITGB3 KCND3 UBE3A CTNNB1 DOT1L ATP2A2 | 2.55e-04 | 590 | 105 | 11 | int:CDK1 |
| Interaction | ILK interactions | 2.66e-04 | 319 | 105 | 8 | int:ILK | |
| Interaction | OTUD1 interactions | 2.66e-04 | 170 | 105 | 6 | int:OTUD1 | |
| Interaction | KCNA5 interactions | 2.71e-04 | 60 | 105 | 4 | int:KCNA5 | |
| Interaction | DKKL1 interactions | 2.89e-04 | 111 | 105 | 5 | int:DKKL1 | |
| Interaction | KCTD13 interactions | FLNB ATP5PO LZTS3 TCP1 RPS3A PCLO CCT2 DDB1 ELFN2 SLC44A1 KCND3 GLUD1 NAV1 DLG1 RIMS1 CTNNB1 FH ATP2A2 | 2.95e-04 | 1394 | 105 | 18 | int:KCTD13 |
| Interaction | PRNP interactions | COL13A1 LZTS3 ERCC6L CHAF1A CCT2 MCM10 DDB1 TXNDC12 PPP1R10 MDN1 FUBP1 GLUD1 DLG1 RIMBP3C ATP1A2 TMX3 | 3.17e-04 | 1158 | 105 | 16 | int:PRNP |
| Interaction | SEPTIN12 interactions | 3.27e-04 | 26 | 105 | 3 | int:SEPTIN12 | |
| Cytoband | 11q12-q13 | 7.87e-05 | 6 | 106 | 2 | 11q12-q13 | |
| Cytoband | 2q22.1 | 4.72e-04 | 14 | 106 | 2 | 2q22.1 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.08e-05 | 3 | 75 | 2 | 287 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.44e-04 | 36 | 75 | 3 | 823 | |
| GeneFamily | Collagens | 9.16e-04 | 46 | 75 | 3 | 490 | |
| GeneFamily | AAA ATPases | 1.38e-03 | 53 | 75 | 3 | 413 | |
| GeneFamily | Chaperonins | 1.72e-03 | 15 | 75 | 2 | 587 | |
| GeneFamily | Protein disulfide isomerases | 3.39e-03 | 21 | 75 | 2 | 692 | |
| GeneFamily | PDZ domain containing | 3.67e-03 | 152 | 75 | 4 | 1220 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.42e-03 | 24 | 75 | 2 | 485 | |
| GeneFamily | PHD finger proteins | 6.22e-03 | 90 | 75 | 3 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.80e-03 | 181 | 75 | 4 | 694 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_500 | 2.13e-06 | 77 | 104 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.28e-06 | 234 | 104 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_500 | 2.33e-06 | 122 | 104 | 7 | gudmap_developingGonad_P2_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.37e-06 | 148 | 104 | 7 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.77e-05 | 230 | 104 | 8 | gudmap_developingGonad_P2_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | GBP7 HNMT ITGB3 RYR3 KCND3 AHNAK SLC22A3 RIMS1 ATP1A2 ATP2A2 | 2.10e-05 | 388 | 104 | 10 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_200 | 2.25e-05 | 34 | 104 | 4 | gudmap_developingGonad_e16.5_epididymis_200_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | ZBTB33 ERCC6L RPS3A NTRK3 HMGB3 MCM10 NEDD1 ELAC2 TYRO3 GK MDN1 FUBP1 NAV1 DLG1 RIMS1 EIF3J SNX5 | 4.84e-05 | 1164 | 104 | 17 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.29e-05 | 197 | 104 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | MACC1 GBP7 HNMT ITGB3 RYR3 SLC44A1 KCND3 AHNAK PKHD1 RAB11FIP5 RIMS1 ATP1A2 ATP2A2 | 6.12e-05 | 734 | 104 | 13 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_500 | 8.52e-05 | 91 | 104 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | ZBTB33 ERCC6L RPS3A NTRK3 HMGB3 ADGRV1 MCM10 NEDD1 ELAC2 TYRO3 GK MDN1 FUBP1 NAV1 DLG1 RIMS1 EIF3J SNX5 | 8.90e-05 | 1347 | 104 | 18 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 8.97e-05 | 92 | 104 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | MACC1 GBP7 HNMT RYR3 SLC44A1 KCND3 AHNAK SLC22A3 PKHD1 RAB11FIP5 RIMS1 ATP1A2 ATP2A2 | 1.04e-04 | 774 | 104 | 13 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.41e-04 | 395 | 104 | 9 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_200 | 2.29e-04 | 61 | 104 | 4 | gudmap_developingGonad_P2_epididymis_200_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | ZBTB33 DDX31 ERCC6L RPS3A DUSP8 HMGB3 ADGRV1 MCM10 KATNA1 NEDD1 MDN1 UBE3A UTP20 EIF3J TMX3 SNX5 | 2.40e-04 | 1202 | 104 | 16 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | ZBTB33 DDX31 ERCC6L RPS3A DUSP8 HMGB3 MCM10 KATNA1 NEDD1 MDN1 UBE3A UTP20 EIF3J TMX3 SNX5 | 2.44e-04 | 1080 | 104 | 15 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_100 | 2.73e-04 | 26 | 104 | 3 | gudmap_developingGonad_e18.5_epididymis_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | COL15A1 GBP7 HNMT ITGB3 RYR3 KCND3 AHNAK SLC22A3 RIMS1 PRKG1 ATP1A2 ATP2A2 | 3.48e-04 | 761 | 104 | 12 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.28e-09 | 200 | 106 | 9 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.28e-09 | 200 | 106 | 9 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.28e-09 | 200 | 106 | 9 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.28e-09 | 200 | 106 | 9 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.28e-09 | 200 | 106 | 9 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.75e-08 | 200 | 106 | 8 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.54e-07 | 189 | 106 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-07 | 198 | 106 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-07 | 198 | 106 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.19e-07 | 200 | 106 | 7 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.19e-07 | 200 | 106 | 7 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.19e-07 | 200 | 106 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.19e-07 | 200 | 106 | 7 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.19e-07 | 200 | 106 | 7 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.19e-07 | 200 | 106 | 7 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-06 | 162 | 106 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.68e-06 | 173 | 106 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-06 | 173 | 106 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-06 | 174 | 106 | 6 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.47e-06 | 179 | 106 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.62e-06 | 180 | 106 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.57e-06 | 186 | 106 | 6 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-06 | 187 | 106 | 6 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-06 | 187 | 106 | 6 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 6.11e-06 | 189 | 106 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 191 | 106 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | COPD-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 7.09e-06 | 194 | 106 | 6 | 72a2e0cba171ab59aa176e91a59a54c562af0390 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.30e-06 | 195 | 106 | 6 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 7.52e-06 | 196 | 106 | 6 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | distal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.97e-06 | 198 | 106 | 6 | dc93886439a378a0c71e99acb8081bfb6b6d467b | |
| ToppCell | normal_Lung-Epithelial_cells-Club|Epithelial_cells / Location, Cell class and cell subclass | 7.97e-06 | 198 | 106 | 6 | a9d0109ca05eb3e9c588f9677ec471dd5c092a75 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.44e-06 | 200 | 106 | 6 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.44e-06 | 200 | 106 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.44e-06 | 200 | 106 | 6 | ed4a41cb6782541d8fc928aaa12cf03bc1c630a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.44e-06 | 200 | 106 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 145 | 106 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 3.38e-05 | 154 | 106 | 5 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 154 | 106 | 5 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 154 | 106 | 5 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-05 | 156 | 106 | 5 | a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-05 | 161 | 106 | 5 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 164 | 106 | 5 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 164 | 106 | 5 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 164 | 106 | 5 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.11e-05 | 168 | 106 | 5 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.11e-05 | 168 | 106 | 5 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 170 | 106 | 5 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.41e-05 | 170 | 106 | 5 | b5b47fe42617a4c2ebb49c8ed55db3926213a75a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 170 | 106 | 5 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 170 | 106 | 5 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 170 | 106 | 5 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 170 | 106 | 5 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-05 | 172 | 106 | 5 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-05 | 172 | 106 | 5 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 174 | 106 | 5 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 175 | 106 | 5 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 175 | 106 | 5 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 0089b50d607f4d2f18639fab0f3fc779227baa7a | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.72e-05 | 178 | 106 | 5 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 178 | 106 | 5 | fce60ce6b662f1bdaa3b4da43800c6c22fe89533 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 178 | 106 | 5 | 5a4f97d19265577cfdb3e53f9dc3a9a02cfcffa9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 178 | 106 | 5 | b19c906e067b07eadfd68934d9330b447e24c708 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.90e-05 | 179 | 106 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-05 | 180 | 106 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-05 | 180 | 106 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.09e-05 | 180 | 106 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | e6a734fb29105093d4cbfc3d0619a825b66da034 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | ccc313ecc0bfd8e2c6bb83a565b427b2310485ec | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.47e-05 | 182 | 106 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | b9f758961fb4a586ae86fa0b25edb8ce4616d644 | |
| ToppCell | severe_influenza-gd_T|severe_influenza / disease group, cell group and cell class (v2) | 7.47e-05 | 182 | 106 | 5 | b6b44c90af3f0c0dddb2b171087865d8c15a3973 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.86e-05 | 184 | 106 | 5 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.06e-05 | 185 | 106 | 5 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 185 | 106 | 5 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-05 | 186 | 106 | 5 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-05 | 186 | 106 | 5 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.27e-05 | 186 | 106 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.48e-05 | 187 | 106 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.70e-05 | 188 | 106 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.70e-05 | 188 | 106 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 188 | 106 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 8.70e-05 | 188 | 106 | 5 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 188 | 106 | 5 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.92e-05 | 189 | 106 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 8.92e-05 | 189 | 106 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.14e-05 | 190 | 106 | 5 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.14e-05 | 190 | 106 | 5 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 191 | 106 | 5 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 9.37e-05 | 191 | 106 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| Drug | N-butylmaleimide | 3.69e-07 | 4 | 104 | 3 | CID000239780 | |
| Drug | lanthanum | 3.05e-06 | 136 | 104 | 7 | CID000023926 | |
| Drug | nitroglycerin | 4.80e-06 | 206 | 104 | 8 | CID000004510 | |
| Drug | phenyltriethoxysilane | 2.07e-05 | 2 | 104 | 2 | CID000013075 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 2.07e-05 | 2 | 104 | 2 | ctd:C005147 | |
| Drug | G-3SH | 2.07e-05 | 2 | 104 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 2.07e-05 | 2 | 104 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 2.07e-05 | 2 | 104 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 2.07e-05 | 2 | 104 | 2 | CID000068137 | |
| Drug | x 1 s | 2.07e-05 | 2 | 104 | 2 | CID000409694 | |
| Drug | rafoxanide | 2.56e-05 | 13 | 104 | 3 | CID000031475 | |
| Drug | hydride | DPYS ATP5PO COX8A CPS1 RYR1 GLUD1 GLUD2 RIMS1 ATP1A2 FH ATP12A BBOX1 ATP2A2 CYB5R1 | 2.66e-05 | 835 | 104 | 14 | CID000000783 |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.80e-05 | 191 | 104 | 7 | 1059_DN | |
| Drug | Furazolidone [67-45-8]; Up 200; 17.8uM; PC3; HT_HG-U133A | 3.20e-05 | 195 | 104 | 7 | 4098_UP | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.76e-05 | 200 | 104 | 7 | 6838_UP | |
| Drug | Gvapspat amide | 4.05e-05 | 15 | 104 | 3 | CID000125015 | |
| Drug | isoflurane | 4.29e-05 | 279 | 104 | 8 | CID000003763 | |
| Drug | glyceollin | 4.97e-05 | 16 | 104 | 3 | CID000162807 | |
| Drug | lifarizine | 6.01e-05 | 17 | 104 | 3 | CID000071336 | |
| Drug | 3-(2,2,2-trimethylhydrazine)propionate | 6.18e-05 | 3 | 104 | 2 | ctd:C050147 | |
| Drug | cis-diammineplatinum(II | 6.18e-05 | 3 | 104 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.18e-05 | 3 | 104 | 2 | CID002750949 | |
| Drug | lenthionine | 6.18e-05 | 3 | 104 | 2 | CID000067521 | |
| Drug | 8N3-cADPR | 6.18e-05 | 3 | 104 | 2 | CID000127713 | |
| Drug | aminodantrolene | 6.18e-05 | 3 | 104 | 2 | CID009570289 | |
| Drug | mildiomycin | 6.18e-05 | 3 | 104 | 2 | CID000125665 | |
| Drug | methoxyethylmercury | 6.18e-05 | 3 | 104 | 2 | CID000115155 | |
| Drug | 4-methylumbelliferyl laurate | 6.18e-05 | 3 | 104 | 2 | CID000600674 | |
| Drug | 2-hydroxycarbazole | 6.18e-05 | 3 | 104 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 6.18e-05 | 3 | 104 | 2 | CID000080262 | |
| Drug | methylmercuric iodide | 6.18e-05 | 3 | 104 | 2 | CID000067347 | |
| Drug | flubendiamide | 6.18e-05 | 3 | 104 | 2 | CID011193251 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.18e-05 | 3 | 104 | 2 | CID005748312 | |
| Drug | valproate | 6.35e-05 | 381 | 104 | 9 | CID000003121 | |
| Drug | Carbamoyl | 8.05e-05 | 50 | 104 | 4 | CID005460723 | |
| Drug | AC1L380G | 8.51e-05 | 19 | 104 | 3 | CID000084698 | |
| Drug | 3-methylcatechol | 8.75e-05 | 98 | 104 | 5 | CID000000340 | |
| Drug | AC1L1GTT | 9.83e-05 | 233 | 104 | 7 | CID000003837 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 9.83e-05 | 233 | 104 | 7 | CID000005114 | |
| Drug | 5-amino-1-phenyltetrazole | 9.97e-05 | 20 | 104 | 3 | CID000021640 | |
| Drug | succinyl-coenzyme A | 1.15e-04 | 166 | 104 | 6 | CID000001111 | |
| Drug | indo-1/AM | 1.16e-04 | 21 | 104 | 3 | CID000123918 | |
| Drug | thionicotinamide | 1.16e-04 | 21 | 104 | 3 | CID000737155 | |
| Drug | hydroxyl radicals | DPYS ATP5PO DUSP8 COX8A CPS1 KATNA1 ITGB3 PTPRN GLUD1 GLUD2 RIMS1 PLD1 ATP1A2 FH ATP12A ATP2A2 PHLPP2 | 1.17e-04 | 1341 | 104 | 17 | CID000000961 |
| Drug | methyl benzoquate | 1.23e-04 | 4 | 104 | 2 | CID000026383 | |
| Drug | A-30 | 1.23e-04 | 4 | 104 | 2 | CID003028528 | |
| Drug | pentenoic acid | 1.23e-04 | 4 | 104 | 2 | CID000012299 | |
| Drug | PCB74 | 1.23e-04 | 4 | 104 | 2 | CID000036218 | |
| Drug | alpha-ketoglutaramate | 1.23e-04 | 4 | 104 | 2 | CID000000048 | |
| Drug | ureidoglycine | 1.23e-04 | 4 | 104 | 2 | CID000439649 | |
| Drug | Ivin | 1.23e-04 | 4 | 104 | 2 | CID000014083 | |
| Drug | 8-BDB-TADP | 1.23e-04 | 4 | 104 | 2 | CID000130791 | |
| Drug | cadina-3,9-diene | 1.23e-04 | 4 | 104 | 2 | CID000010657 | |
| Drug | AC1L9CUQ | 1.23e-04 | 4 | 104 | 2 | CID000442451 | |
| Drug | 148504-47-6 | 1.23e-04 | 4 | 104 | 2 | CID006444275 | |
| Drug | Bastadin 10 | 1.23e-04 | 4 | 104 | 2 | CID009589366 | |
| Drug | SC 38249 | 1.23e-04 | 4 | 104 | 2 | CID000134834 | |
| Drug | luxabendazole | 1.23e-04 | 4 | 104 | 2 | CID000072019 | |
| Drug | AC1L1U7A | 1.23e-04 | 4 | 104 | 2 | CID000035682 | |
| Drug | alpha-methylglutamate | 1.23e-04 | 4 | 104 | 2 | CID000095440 | |
| Drug | 2b E2 | 1.23e-04 | 4 | 104 | 2 | CID005327076 | |
| Drug | lithium sulfate monohydrate | 1.34e-04 | 22 | 104 | 3 | CID000165815 | |
| Drug | D-pyroglutamate | 1.64e-04 | 112 | 104 | 5 | CID000000499 | |
| Drug | succinate | 1.66e-04 | 339 | 104 | 8 | CID000001110 | |
| Drug | AC1L9M3B | 1.76e-04 | 61 | 104 | 4 | CID000448562 | |
| Drug | HMS3267E16 | 1.87e-04 | 62 | 104 | 4 | CID000003668 | |
| Drug | lamotrigine | 1.94e-04 | 116 | 104 | 5 | CID000003878 | |
| Drug | potassium | ATP5PO MYO1A CPS1 RYR1 RYR3 KCND3 SCN4A GLUD1 DLG1 PRKG1 ATP1A2 ATP12A BBOX1 ATP2A2 | 1.97e-04 | 1008 | 104 | 14 | CID000000813 |
| Drug | Gg P | 1.98e-04 | 25 | 104 | 3 | CID005288387 | |
| Drug | N-phenylmaleimide | 1.98e-04 | 25 | 104 | 3 | CID000013662 | |
| Drug | AC1MPJID | 2.02e-04 | 117 | 104 | 5 | CID003386230 | |
| Drug | NH4Cl | 2.02e-04 | 184 | 104 | 6 | CID000025517 | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 2.05e-04 | 5 | 104 | 2 | ctd:C001079 | |
| Drug | bathocuproine | 2.05e-04 | 5 | 104 | 2 | CID000065149 | |
| Drug | AC1NRA4I | 2.05e-04 | 5 | 104 | 2 | CID005287695 | |
| Drug | isosteviol lactone | 2.05e-04 | 5 | 104 | 2 | CID000401559 | |
| Drug | 1-pheg | 2.05e-04 | 5 | 104 | 2 | CID000152041 | |
| Drug | 5'-FSBAzA | 2.05e-04 | 5 | 104 | 2 | CID000130430 | |
| Drug | adenine N1-oxide | 2.05e-04 | 5 | 104 | 2 | CID000093557 | |
| Drug | choline sulfate | 2.05e-04 | 5 | 104 | 2 | CID000000485 | |
| Drug | l-413 | 2.05e-04 | 5 | 104 | 2 | CID000012475 | |
| Drug | 3-aminopicolinate | 2.05e-04 | 5 | 104 | 2 | CID000073836 | |
| Drug | Sulfaphenazole [526-08-9]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.21e-04 | 187 | 104 | 6 | 1794_UP | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.27e-04 | 188 | 104 | 6 | 1832_UP | |
| Drug | propofol | 2.47e-04 | 191 | 104 | 6 | CID000004943 | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.69e-04 | 194 | 104 | 6 | 5056_UP | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | 2.69e-04 | 194 | 104 | 6 | 4573_UP | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A | 2.69e-04 | 194 | 104 | 6 | 6712_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.76e-04 | 195 | 104 | 6 | 4063_UP | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.84e-04 | 196 | 104 | 6 | 5011_UP | |
| Drug | bepridil | 2.85e-04 | 126 | 104 | 5 | CID000002351 | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.92e-04 | 197 | 104 | 6 | 5633_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A | 2.92e-04 | 197 | 104 | 6 | 3694_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.92e-04 | 197 | 104 | 6 | 3621_UP | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HT_HG-U133A | 3.00e-04 | 198 | 104 | 6 | 4650_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.00e-04 | 198 | 104 | 6 | 6341_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.00e-04 | 198 | 104 | 6 | 6088_UP | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; HL60; HT_HG-U133A | 3.00e-04 | 198 | 104 | 6 | 1849_DN | |
| Drug | alpha-monofluoromethylputrescine | 3.06e-04 | 6 | 104 | 2 | CID000134201 | |
| Drug | Antithymocyte globulin | 3.06e-04 | 6 | 104 | 2 | DB00098 | |
| Disease | internet addiction disorder | 4.53e-06 | 33 | 99 | 4 | EFO_0803368 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | fascioliasis (biomarker_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | Hypokalemic periodic paralysis | 6.66e-05 | 4 | 99 | 2 | C0238358 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.54e-04 | 31 | 99 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Comatose | 1.66e-04 | 6 | 99 | 2 | C0009421 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 1.66e-04 | 6 | 99 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.28e-04 | 163 | 99 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 2.31e-04 | 7 | 99 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Hyperammonemia | 2.31e-04 | 7 | 99 | 2 | C0220994 | |
| Disease | executive function measurement | 2.81e-04 | 376 | 99 | 7 | EFO_0009332 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.18e-04 | 195 | 99 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 7.20e-04 | 12 | 99 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 7.20e-04 | 12 | 99 | 2 | C0270960 | |
| Disease | gluteofemoral adipose tissue measurement | 1.04e-03 | 132 | 99 | 4 | EFO_0803317 | |
| Disease | Prostatic Neoplasms | 1.12e-03 | 616 | 99 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.12e-03 | 616 | 99 | 8 | C0376358 | |
| Disease | glycerate measurement | 1.14e-03 | 15 | 99 | 2 | EFO_0021029 | |
| Disease | response to olanzapine | 1.14e-03 | 15 | 99 | 2 | GO_0097333 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.14e-03 | 15 | 99 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | pemphigus vulgaris | 1.30e-03 | 16 | 99 | 2 | EFO_0004719 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.30e-03 | 16 | 99 | 2 | C0751885 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.47e-03 | 17 | 99 | 2 | C0751883 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.47e-03 | 17 | 99 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.74e-03 | 152 | 99 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | metabolite measurement, diet measurement | 1.77e-03 | 71 | 99 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.84e-03 | 19 | 99 | 2 | C0751884 | |
| Disease | Autistic Disorder | 1.90e-03 | 261 | 99 | 5 | C0004352 | |
| Disease | colorectal cancer (is_marker_for) | 1.96e-03 | 157 | 99 | 4 | DOID:9256 (is_marker_for) | |
| Disease | non-small cell lung carcinoma | 2.08e-03 | 75 | 99 | 3 | EFO_0003060 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.08e-03 | 75 | 99 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.50e-03 | 80 | 99 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | waist-hip ratio | COL15A1 BIRC6 ITGB3 SLC44A1 AHNAK SLC22A3 SCN4A DLG1 RIMS1 PLD1 DOT1L | 2.72e-03 | 1226 | 99 | 11 | EFO_0004343 |
| Disease | Myasthenic Syndromes, Congenital | 2.93e-03 | 24 | 99 | 2 | C0751882 | |
| Disease | alcohol consumption measurement | DDX31 PCLO ADGRV1 THSD7B CPS1 KATNA1 BIRC6 TYRO3 PKHD1 ABCG8 PHLPP2 | 3.00e-03 | 1242 | 99 | 11 | EFO_0007878 |
| Disease | urinary albumin to creatinine ratio | 3.15e-03 | 179 | 99 | 4 | EFO_0007778 | |
| Disease | cholelithiasis | 3.27e-03 | 88 | 99 | 3 | EFO_0004799 | |
| Disease | descending aortic diameter | 3.27e-03 | 88 | 99 | 3 | EFO_0021788 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.28e-03 | 181 | 99 | 4 | DOID:684 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGVEAGKGLEMRKLV | 81 | Q12979 | |
| SGDKPEAVMVIGKGL | 756 | Q8NDL9 | |
| EGIPKITGKGMVSLN | 1096 | Q9HCE6 | |
| LTLTSPKLVKGMAGG | 1201 | Q9NR09 | |
| MDAKKLASLLRGGPG | 11 | Q13202 | |
| DKGEIPDDMGSKGLK | 666 | Q12959 | |
| DGNAMPRGIKSLKGE | 1441 | Q8WXG9 | |
| MAGKAAEERGLPKGA | 1 | Q9H221 | |
| LPEIATGGLEGKMKG | 471 | Q09666 | |
| MGEKLELRLKSPVGA | 1 | Q8TEK3 | |
| SEAGGILFKGKVPMV | 226 | Q13111 | |
| GPKLLAETADMIGVK | 291 | Q9NZU7 | |
| LLLAGPSGVGKKMLV | 571 | Q86XH1 | |
| LKLEAKTDPSILGGM | 171 | P48047 | |
| ALDDILGGGVPLMKT | 106 | O43502 | |
| LEMGGSAAPAAPKLK | 821 | A6NNM3 | |
| LEMGGSAAPAAPKLK | 821 | A6NJZ7 | |
| AIEDPDLGSLGKMGK | 216 | Q9BXF6 | |
| LPGQMGKLAESEGTK | 146 | Q7Z2G1 | |
| IFKSGGIPALVKMLG | 231 | P35222 | |
| VGADIKKTMEGPVEG | 381 | Q16849 | |
| VPKVMAGLLTLDGKV | 91 | Q8NGN2 | |
| GDMVPKTIAGKIFGS | 371 | Q9UK17 | |
| PKCLGEGGKAITMEI | 2156 | Q9NU22 | |
| LKGGLDKSRTMTPAG | 196 | O60299 | |
| DGMLSGEKGVPKTGL | 191 | A2A368 | |
| MGKGTVAVQEKAGLP | 361 | Q8NHV4 | |
| MAASKKAVLGPLVGA | 1 | Q14409 | |
| DPGVGSKHLMEGQKI | 401 | Q86T24 | |
| GSPSLCLLKLMGEKG | 86 | Q9UDY8 | |
| KFGMKGPVAVISGEE | 461 | Q16288 | |
| KGGEEGPVLMAEAVK | 886 | Q9UBC5 | |
| MIPASKAGLVIGKGG | 191 | Q96AE4 | |
| VVPGGGLKATMKDDL | 226 | O75822 | |
| TKEGVKLCTMGPGKV | 151 | Q13976 | |
| KLCTMGPGKVFGELA | 156 | Q13976 | |
| DSPALKKADIGIAMG | 736 | P54707 | |
| MSDGLPALVTLKKGL | 2126 | Q2LD37 | |
| EGAKKMLALGITGPE | 201 | Q14117 | |
| ELGVTMKGPKGLEEL | 486 | O75369 | |
| MDKKLPGIIGRIGDT | 36 | P50135 | |
| KILPGGSAEQTGKLM | 4536 | Q9Y6V0 | |
| AALPGAAKLVDLGMK | 606 | Q8N8V2 | |
| KLGQVFVKMAGEGEP | 2196 | Q9UMN6 | |
| MLKEKTGPKIGGETL | 846 | Q7L590 | |
| EMEKSALGGGKLPRG | 36 | Q6NUT2 | |
| VPGVLMGGEKRKSEK | 336 | Q9H8H2 | |
| RKEIFSGLPELKGMG | 181 | Q8TEA1 | |
| DSGALLGLKVVGGKM | 611 | Q86UR5 | |
| DAPALKKAEIGIAMG | 706 | P16615 | |
| ALKKADIGIAMGISG | 721 | P50993 | |
| KGTMLGKIEFEGQPV | 176 | P31327 | |
| IKAQVSEGKGRLMPG | 526 | Q96AY3 | |
| TMELAKKGFIGPGID | 206 | P00367 | |
| AIEMLGGELGSKIPV | 161 | P07954 | |
| LMEEKFPGDAGLGKL | 51 | Q6K0P9 | |
| SDKPGEVSKLGKRMG | 156 | O75936 | |
| MAASKKAVLGPLVGA | 1 | P32189 | |
| ISGGELGPTMKLKRL | 691 | Q96GR2 | |
| MPGQLTISDIKKGGK | 396 | Q6ZN28 | |
| PEGKLGIMELAVGLT | 31 | P10176 | |
| PGISIGDVAKKLGEM | 116 | O15347 | |
| IPGLKSCMGLKIGDT | 406 | P05106 | |
| LMVGPPGTGKTLLAK | 246 | O75449 | |
| AGKGGVADSRELKPM | 636 | Q8WWI5 | |
| LKEVKMEGARLGLPG | 76 | Q6ZN92 | |
| AKGAPGIAVAGMKGE | 331 | Q5TAT6 | |
| LNGLKGTKGDPGVIM | 916 | P39059 | |
| GGLVMLLPETKGIAL | 511 | O75751 | |
| GGGESKEIRFPKMVT | 2216 | P21817 | |
| EIDPEKGKITGGGMV | 456 | Q6ZTR5 | |
| AEGLRPVKEVGMYGK | 46 | Q16531 | |
| TMELAKKGFIGPGVD | 206 | P49448 | |
| KGARGKMISAGLPGE | 1691 | A6NMZ7 | |
| KGGILADDMGLGKTV | 116 | Q2NKX8 | |
| MLPGKFLGRGLDKEV | 831 | O14654 | |
| GLGKVGSKGREAPLM | 121 | Q8NEY1 | |
| LGAVAMDLGIDKVKP | 2651 | O75691 | |
| TQGPLKKIMEACAGG | 206 | Q8TEB9 | |
| GKILSPKDIMLSLGE | 846 | P35499 | |
| ISGMVKLEKSKPGLG | 911 | Q4G0N8 | |
| DLGPKGIEGMIMKRS | 216 | Q13393 | |
| LEMGGSAAPAAPKLK | 821 | Q9UFD9 | |
| PKFELGKLMELHGEG | 221 | P61247 | |
| IVKSSLGPVGLDKML | 31 | P17987 | |
| LGPVGLDKMLVDDIG | 36 | P17987 | |
| GDLVKSTLGPKGMDK | 36 | P78371 | |
| GTGVKGAKPMEEIVT | 2081 | P08F94 | |
| LKEKMEAGRGVPNGI | 1121 | P20701 | |
| AKKLGMIAGGTGITP | 176 | Q9UHQ9 | |
| PSIIGKLKVAGMLAV | 481 | Q08188 | |
| VGLEMKSIGSPVKVG | 66 | Q96JJ7 | |
| LMASGKEVAGKIPKG | 781 | Q8NBP0 | |
| GTDRAPVGGLGKLKM | 811 | Q05086 | |
| VLKAKEMGLPVGTAA | 256 | Q9BQ52 | |
| TGKMHILPLVGGKIE | 191 | Q6ZVD8 | |
| EPYLGRIEIMGGAKK | 4026 | Q15413 | |
| GVKMKLTVIDTPGFG | 116 | Q9UH03 | |
| MAPSGLKAVVGEKIL | 1 | Q15833 | |
| TGSGRGKKLMVLTEP | 231 | Q6ZUI0 | |
| MKKSIGILSPGVALG | 1 | P41221 | |
| GPREKMQKLGEGEGS | 101 | Q9Y5X3 | |
| GAEKEMLGSSLIKPL | 1581 | Q9UPU5 | |
| ILVLKKDGLGMTLPS | 161 | Q9UPP1 | |
| MAIGGGKECPELLEK | 371 | Q9C0I4 | |
| MGSGPIDPKELLKGL | 1 | Q96QC0 | |
| GKKEAAASGLPLMVI | 46 | O95881 | |
| AGLKLMGAPVKLTVS | 41 | Q06418 | |
| GFAKAGKLLVVPMDG | 21 | Q9HAW7 | |
| MIGEKLPTAKGLEAG | 476 | Q5R3F8 | |
| LREGSGKDMPKVQGL | 1336 | P41229 |